Skip to Main Content

INFORMATION FOR

    Adjunct Faculty

    Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.

    Adjunct rank details

    John Seibyl, MD

    Professor Adjunct

    About

    Titles

    Professor Adjunct

    Biography

    John Seibyl, M.D. is Distinguished Scientist and Chairman of the Board of the Institute for Neurodegenerative Disorders (IND) in New Haven, CT. Prior to IND, Dr. Seibyl was Chief, Section of Nuclear Medicine and Associate Professor of Diagnostic Radiology and Psychiatry, Yale University School of Medicine. He is a pioneer in the use of Dopamine Transporter (DaT) SPECT imaging for the assessment of Parkinson’s disease and related disorders. He serves on the editorial board of the European Journal of Nuclear Medicine and is a frequent reviewer for top-tier nuclear imaging journals. He serves on international panels for his work in neurodegenerative disease imaging. He recently re-joined Yale as Adjunct Professor of Neurology.

    Last Updated on August 10, 2026.

    Appointments

    Other Departments & Organizations

    Education & Training

    MD
    Case Western Reserve Univ (1986)

    Research

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of John Seibyl's published research.

    Publications

    2026

    • Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease
      Brendel M, Kuo P, Brumberg J, Doré V, Drzezga A, Garibotto V, Leuzy A, Mathoux G, Meyer P, Moscoso A, Ossenkoppele R, Pascoal T, Smith R, Seibyl J, van de Giessen E, Van Weehaeghe D, Vermeiren M, Villemagne V, Esfahani S, Barthel H, Committee T, Brendel M, Cecchin D, Fernandez P, Guedj E, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Verger A, Yakushev I. Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease. The EANM Journal 2026, 3: 100214. DOI: 10.1016/j.eanmj.2026.100214.
      Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
    • Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
      Gonzalez‐Latapi P, Gochanour C, Choi S, Cho H, Caspell‐Garcia C, Coffey C, Brumm M, Lafontant D, Xiao Y, Tropea T, Seibyl J, Tanner C, Venuto C, Kieburtz K, Chahine L, Poston K, Siderowf A, Marek K, Simuni T, Initiative T. Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease. Annals Of Clinical And Translational Neurology 2026 PMID: 41808287, DOI: 10.1002/acn3.70323.
      Peer-Reviewed Original Research
    • Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
      Fan Z, Searle G, Rizzo G, Albani J, Cella P, Comley R, Klein G, Passamonti L, Salinas C, Schwarz A, Iaccarino L, Tamagnan G, Eberling J, Marek K, Seibyl J, Gunn R, Marek K, Tanner C, Simuni T, Siderowf A, Galasko D, Chahine L, Coffey C, Merchant K, Poston K, Dobkin R, Foroud T, Mollenhauer B, Weintraub D, Brown E, Kieburtz K, Frasier M, Sherer T, Chowdhury S, Alcalay R, Videnovic A, Tosun‐Turgut D, Poewe W, Bressman S, Hammer J, James R, Riley E, Seibyl J, Shaw L, Standaert D, Mantri S, Dahodwala N, Schwarzschild M, Marras C, Fernandez H, Shoulson I, Rowbotham H, Casalin P, Trenkwalder C, Sherer T, Chowdhury S, Frasier M, Eberling J, Kopil K, O'Grady A, Kuhl M, Kirsch L, Willson T, Adler C, Alcalay R, Amara A, Barone P, Bloem B, Bressman S, Brockmann K, Brüggemann N, Chahine L, Chou K, Dahodwala N, Espay A, Factor S, Fernandez H, Fullard M, Galasko D, Hauser R, Hogarth P, Hu S, Hu M, Isaacson S, Klein C, Krueger R, Lew M, Mari Z, Marras C, Martí M, McFarland N, Mestre T, Mollenhauer B, Moukheiber E, Noyce A, Okubadejo N, O'Shea S, Pahwa R, Pavese N, Poewe W, Postuma R, Riboldi G, Ruffrage L, Martinez J, Russell D, Saint‐Hilaire M, Santos N, Schlett47 W, Schneider R, Shill H, Shprecher D, Simuni T, Standaert D, Stefanis L, Tai Y, Tanner C, Tarakad A, PhD34 E, Videnovic A, Ainscough S, Blair C, Botting E, Chung I, Clark K, Croitoru I, DeLano K, Egner I, Esha F, Eshel M, Ferrari F, Foster V, Garrido A, Grümmer M, Herrera B, Hilt E, Huntzinger C, James R, Kausar F, Koros C, Krasowski60 Y, Le D, Liu Y, Marques T, Santana H, Mosovsky S, Mule J, Ng P, O'Brien L, Ogunleye A, Ojo O, Onyinanya O, Pennente L, Perrotti R, Pileggi M, Ramachandran A, Raymond D, Razzaque J, Reddie S, Ribb K, Rizer K, Rodriguez J, Roman S, Sanchez C, Simonet C, Singh A, Sittig E, Sommerfeld B, Stovall A, Stubbeman B, Valenzuela A, Wandell C, Willeke D, Williams K, Wubuli D. Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale. Annals Of Neurology 2026, 99: 949-963. PMID: 41556298, PMCID: PMC13011789, DOI: 10.1002/ana.78116.
      Peer-Reviewed Original Research

    2025

    2024

    2023